Stock Region Penny Picks
Your Stock Region Penny Picks Watchlist for Monday, May 19, 2025.
Your Stock Region Penny Picks Watchlist for Monday, May 19, 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: The information provided in this newsletter is for informational purposes only and does not constitute investment advice. Always conduct your own research or consult a financial advisor before making investment decisions.
$BCLI - BrainStorm Advances NurOwn® for ALS
BrainStorm Cell Therapeutics received FDA clearance to initiate a Phase 3b trial of NurOwn®, its promising treatment for ALS. This milestone positions the company to further its work in tackling this neurodegenerative disease.
$QNTM - Expanding Digital Asset Holdings
Quantum Biopharma has doubled down on crypto, purchasing an additional $1 million in Bitcoin and other cryptocurrencies. This raises its total digital asset investment to $4.5 million, part of its broader strategy to generate staking revenue.
$PTIX - Protagenic Therapeutics Merges with Phytanix Bio
Protagenic Therapeutics, Inc. and Phytanix Bio are combining forces in an all-stock transaction. The newly formed Phytanix, Inc. will focus on stress-related and central nervous system (CNS) disorders, operating with five preclinical and one clinical-stage asset.
$AIMD - Promising Results in Companion Animal Immunotherapy
Ainos has announced breakthrough interim results in its VELDONA clinical trial for feline chronic gingivostomatitis (FCGS). These advancements mark a significant step forward in companion animal immunotherapy.
$ARMP - Armata Pharmaceuticals Price Target Raised
HC Wainwright & Co. maintained its "Buy" rating for Armata Pharmaceuticals while raising the price target to $9. This revision underscores the growing optimism around the company's potential.
$XTIA - XTI Aerospace Strengthens Financial Position
XTI Aerospace reported a strong Q1 2025, eliminating legacy debt and advancing its TriFan 600 program toward FAA certification. The company also authorized a $5 million share repurchase program to address undervaluation concerns.
Disclaimer: Stock Region is not responsible for any investment decisions made based on the content of this newsletter. Investing in financial markets involves risks, including loss of capital. Always invest responsibly.
We are working endlessly to provide free insights on the stock market every day, and greatly appreciate those who are paid members supporting the development of the Stock Region mobile application. Stock Region offers daily stock and option signals, watchlists, earnings reports, technical and fundamental analysis reports, virtual meetings, learning opportunities, analyst upgrades and downgrades, catalyst reports, in-person events, and access to our private network of investors for paid members as an addition to being an early investor in Stock Region. We recommend all readers to urgently activate their membership before reaching full member capacity (500) to be eligible for the upcoming revenue distribution program. Memberships now available at https://stockregion.net